Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» verubecestat
verubecestat
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Merck study may signal doom for a broad group of pivotal Alzheimer’s studies
Endpoints
Thu, 05/3/18 - 11:43 am
BACE
Alzheimer's disease
Merck
verubecestat
Merck scraps another late-stage Alzheimer's drug study
Yahoo/Reuters
Wed, 02/14/18 - 11:55 pm
Merck
Alzheimer's disease
verubecestat
Merck just dashed the last remaining hopes for its industry-leading BACE drug for Alzheimer’s
Endpoints
Tue, 02/13/18 - 11:14 pm
Merck
BACE inhibitors
Alzheimer's disease
verubecestat
Merck stopping late stage study as another Alzheimer's drug fails
Yahoo/Reuters
Tue, 02/14/17 - 07:43 pm
Merck
Alzheimer's disease
verubecestat
clinical trials
Merck can’t prove its Alzheimer’s drug works, yet, but it did just explain why it’s spending a fortune on PhIII
Endpoints
Thu, 11/3/16 - 09:49 am
Merck
Alzheimer's disease
verubecestat
clinical trials